Clinical Report: Obstetric and Perinatal Outcomes in Women Aged 40 and Above Conceiving via IVF
Overview
This study evaluates obstetric and perinatal outcomes in women aged 40 and older who conceived through IVF. Key findings indicate a higher incidence of complications, particularly in women aged 45 and older, highlighting the need for further research in this demographic.
Background
The trend of women postponing childbearing until their late 30s and 40s has increased significantly, influenced by various social and economic factors. Advanced maternal age (AMA) is associated with higher risks of adverse pregnancy outcomes, necessitating a better understanding of the implications of IVF in this population. Despite the advancements in assisted reproductive technologies, the outcomes for women conceiving at AMA remain underrepresented in clinical literature.
Data Highlights
Outcome
Frequency
Gestational Diabetes Mellitus
3 (2.34%)
Hypertensive Disorders
6 (4.76%)
Preterm Premature Rupture of Membranes
11 (8.59%)
Preterm Intrauterine Growth Restriction
7 (5.56%)
Preterm Delivery
15 (11.72%)
Cesarean Delivery
62 (49.6%)
Newborns Requiring ICU Admission
8 (6.45%)
Key Findings
128 women aged 40 and older were included in the study.
46.88% of participants were primigravid.
55.47% of pregnancies resulted from oocyte donation.
Significantly higher rates of preterm complications were observed in women aged 45 and older.
The median birth weight was 3,028 g, with a median umbilical cord pH of 7.29.
Respiratory complications were the most frequent postnatal comorbidity, affecting 12 out of 14 infants.
Clinical Implications
Healthcare providers should be aware of the increased risks associated with pregnancies in women of advanced maternal age, particularly those over 45. Regular monitoring and tailored prenatal care may be necessary to manage potential complications effectively.
Conclusion
The study highlights significant obstetric and neonatal complications in women aged 40 and above conceiving via IVF, particularly in those aged 45 and older. Further research is warranted to enhance understanding and management of this patient population.
